Atlas Trials

EBV-TCR-T(YT-E001)for Patients With EBV-positive Recurrent or Metastatic NPC

Clinical trial NCT03648697 · UNKNOWN

Trial details

NCT number
NCT03648697
Sponsor
Fujian Cancer Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2018-10-10
Primary completion
2021-10-08
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.